Trillium Therapeutics shares soar on Pfizer’s $2.26B deal


Trillium Therapeutics shares soar on Pfizer’s $2.26B deal


Pfizer's $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.

Comments

Popular posts from this blog

उपत्यका प्रहरी केन्द्र मातहत रहने, महानगरीय प्रहरीको अवधारणा खारेज हुने